Sabra Health Care REIT (NASDAQ:SBRA – Get Free Report) was upgraded by Citizens Jmp from a “hold” rating to a “strong-buy” rating in a research report issued on Tuesday,Zacks.com reports.
Several other equities research analysts have also recently weighed in on the stock. Citigroup raised shares of Sabra Health Care REIT from a “neutral” rating to a “buy” rating and upped their price objective for the stock from $17.00 to $20.00 in a research report on Friday, September 13th. Mizuho reaffirmed a “neutral” rating and set a $20.00 price target on shares of Sabra Health Care REIT in a report on Thursday, December 5th. Scotiabank boosted their price objective on shares of Sabra Health Care REIT from $17.00 to $18.00 and gave the company a “sector perform” rating in a research report on Friday, October 11th. Wells Fargo & Company raised Sabra Health Care REIT from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $16.00 to $20.00 in a report on Tuesday, October 1st. Finally, JMP Securities raised Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 price target for the company in a report on Tuesday. Two investment analysts have rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, Sabra Health Care REIT presently has a consensus rating of “Moderate Buy” and a consensus target price of $19.25.
Read Our Latest Report on Sabra Health Care REIT
Sabra Health Care REIT Trading Up 1.0 %
Sabra Health Care REIT (NASDAQ:SBRA – Get Free Report) last issued its quarterly earnings results on Thursday, October 31st. The real estate investment trust reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.35 by ($0.22). Sabra Health Care REIT had a net margin of 14.20% and a return on equity of 3.51%. The company had revenue of $178.00 million during the quarter, compared to the consensus estimate of $177.19 million. During the same quarter last year, the firm posted $0.34 earnings per share. As a group, sell-side analysts forecast that Sabra Health Care REIT will post 1.39 EPS for the current year.
Institutional Trading of Sabra Health Care REIT
Several large investors have recently modified their holdings of SBRA. Quarry LP acquired a new position in Sabra Health Care REIT during the third quarter worth $30,000. Assetmark Inc. boosted its position in shares of Sabra Health Care REIT by 168.4% during the third quarter. Assetmark Inc. now owns 1,962 shares of the real estate investment trust’s stock valued at $37,000 after buying an additional 1,231 shares during the last quarter. Wilmington Savings Fund Society FSB bought a new stake in Sabra Health Care REIT during the third quarter worth $59,000. Harbor Capital Advisors Inc. purchased a new stake in Sabra Health Care REIT in the 3rd quarter valued at $78,000. Finally, GAMMA Investing LLC lifted its stake in Sabra Health Care REIT by 25.3% during the 3rd quarter. GAMMA Investing LLC now owns 4,614 shares of the real estate investment trust’s stock valued at $86,000 after acquiring an additional 932 shares in the last quarter. Institutional investors and hedge funds own 99.40% of the company’s stock.
Sabra Health Care REIT Company Profile
As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.
Featured Stories
- Five stocks we like better than Sabra Health Care REIT
- What is Short Interest? How to Use It
- 100% Upside? Amprius Technologies Is Charged for Growth in 2025
- The Significance of Brokerage Rankings in Stock Selection
- The 5 Stocks Congress Bought Most in 2024: Top Picks for 2025
- What is a support level?
- 3 Stocks Set to Benefit From Trump’s “Drill, Baby, Drill” Policy
Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.